- Report
- February 2025
- 183 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- June 2024
- 250 Pages
Global
From €2291EUR$2,400USD£1,919GBP
- Report
- October 2024
- 184 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- October 2024
- 199 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- February 2025
- 100 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- July 2024
- 150 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- March 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- March 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- March 2025
- 175 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- January 2025
- 135 Pages
Global
From €2862EUR$2,999USD£2,398GBP
- Report
- May 2024
- 134 Pages
Global
From €6203EUR$6,499USD£5,197GBP
- Report
- July 2024
- 150 Pages
Global
From €3579EUR$3,750USD£2,999GBP
- Clinical Trials
- June 2024
- 60 Pages
Global
From €1432EUR$1,500USD£1,199GBP
- Report
- January 2025
- 880 Pages
Global
From €7587EUR$7,950USD£6,357GBP
- Clinical Trials
- December 2024
- 240 Pages
Global
From €2863EUR$3,000USD£2,399GBP
- Drug Pipelines
- August 2024
- 180 Pages
Global
From €2386EUR$2,500USD£1,999GBP

Docetaxel is a chemotherapy drug used in the treatment of various types of cancer, including breast, ovarian, and non-small cell lung cancer. It is a semi-synthetic derivative of a natural substance found in the bark of the European yew tree. Docetaxel works by interfering with the growth of cancer cells, preventing them from dividing and spreading. It is usually administered intravenously, and is often used in combination with other drugs.
Docetaxel is a widely used oncology drug, and is often prescribed as a first-line treatment for certain types of cancer. It is also used in the treatment of advanced or metastatic cancer, and is sometimes used in combination with other drugs to improve the effectiveness of treatment.
Some companies in the Docetaxel market include Bristol-Myers Squibb, Pfizer, and Sanofi. Show Less Read more